serological test
The company said the improvements it has made to its business during the pandemic will translate to significant increases in growth once it ends.
The firm saw revenues grow 10 percent in Q2, in part driven by PCR-based COVID-19 testing, as it increased production capacity to 10 million tests per week.
Enzo Biochem Q3 Revenues Down 14 Percent
The company said clinical services revenues and diagnostic testing volumes fell during the quarter due to the negative impact of the COVID-19 pandemic.
Sema4 Forms Coronavirus Testing Alliance With Connecticut
Sema4 said it will provide SARS-CoV-2 viral and antibody testing to Connecticut residents including state employees and first responders.